Global Oncology (Anti-cancer Drugs) Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Oncology (Anti-cancer Drugs) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Blood Cancer
  • 1.2.3 Breast Cancer
  • 1.2.4 Gastrointestinal Cancer
  • 1.2.5 Prostate Cancer
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Oncology (Anti-cancer Drugs) Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Chemotherapy
  • 1.3.3 Targeted Therapy
  • 1.3.4 Immunotherapy (Biologic Therapy)
  • 1.3.5 Hormonal Therapy
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Oncology (Anti-cancer Drugs) Market Perspective (2016-2027)
• 2.2 Oncology (Anti-cancer Drugs) Growth Trends by Regions
  • 2.2.1 Oncology (Anti-cancer Drugs) Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Oncology (Anti-cancer Drugs) Historic Market Share by Regions (2016-2021)
  • 2.2.3 Oncology (Anti-cancer Drugs) Forecasted Market Size by Regions (2022-2027)
• 2.3 Oncology (Anti-cancer Drugs) Industry Dynamic
  • 2.3.1 Oncology (Anti-cancer Drugs) Market Trends
  • 2.3.2 Oncology (Anti-cancer Drugs) Market Drivers
  • 2.3.3 Oncology (Anti-cancer Drugs) Market Challenges
  • 2.3.4 Oncology (Anti-cancer Drugs) Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Oncology (Anti-cancer Drugs) Players by Revenue
  • 3.1.1 Global Top Oncology (Anti-cancer Drugs) Players by Revenue (2016-2021)
  • 3.1.2 Global Oncology (Anti-cancer Drugs) Revenue Market Share by Players (2016-2021)
• 3.2 Global Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Oncology (Anti-cancer Drugs) Revenue
• 3.4 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio
  • 3.4.1 Global Oncology (Anti-cancer Drugs) Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Oncology (Anti-cancer Drugs) Revenue in 2020
• 3.5 Oncology (Anti-cancer Drugs) Key Players Head office and Area Served
• 3.6 Key Players Oncology (Anti-cancer Drugs) Product Solution and Service
• 3.7 Date of Enter into Oncology (Anti-cancer Drugs) Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Oncology (Anti-cancer Drugs) Breakdown Data by Type

• 4.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Type (2016-2021)
• 4.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Type (2022-2027)

5 Oncology (Anti-cancer Drugs) Breakdown Data by Application

• 5.1 Global Oncology (Anti-cancer Drugs) Historic Market Size by Application (2016-2021)
• 5.2 Global Oncology (Anti-cancer Drugs) Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Oncology (Anti-cancer Drugs) Market Size (2016-2027)
• 6.2 North America Oncology (Anti-cancer Drugs) Market Size by Type
  • 6.2.1 North America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
  • 6.2.2 North America Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
  • 6.2.3 North America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
• 6.3 North America Oncology (Anti-cancer Drugs) Market Size by Application
  • 6.3.1 North America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
  • 6.3.2 North America Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
  • 6.3.3 North America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
• 6.4 North America Oncology (Anti-cancer Drugs) Market Size by Country
  • 6.4.1 North America Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
  • 6.4.2 North America Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.3 Canada

7 Europe

• 7.1 Europe Oncology (Anti-cancer Drugs) Market Size (2016-2027)
• 7.2 Europe Oncology (Anti-cancer Drugs) Market Size by Type
  • 7.2.1 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
  • 7.2.2 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
  • 7.2.3 Europe Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
• 7.3 Europe Oncology (Anti-cancer Drugs) Market Size by Application
  • 7.3.1 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
  • 7.3.2 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
  • 7.3.3 Europe Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
• 7.4 Europe Oncology (Anti-cancer Drugs) Market Size by Country
  • 7.4.1 Europe Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
  • 7.4.2 Europe Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size (2016-2027)
• 8.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type
  • 8.2.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
• 8.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application
  • 8.3.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
• 8.4 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region
  • 8.4.1 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific Oncology (Anti-cancer Drugs) Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Oncology (Anti-cancer Drugs) Market Size (2016-2027)
• 9.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Type
  • 9.2.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
  • 9.2.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
  • 9.2.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
• 9.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Application
  • 9.3.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
  • 9.3.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
  • 9.3.3 Latin America Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
• 9.4 Latin America Oncology (Anti-cancer Drugs) Market Size by Country
  • 9.4.1 Latin America Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
  • 9.4.2 Latin America Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size (2016-2027)
• 10.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type
  • 10.2.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Type (2016-2027)
• 10.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application
  • 10.3.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Application (2016-2027)
• 10.4 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country
  • 10.4.1 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa Oncology (Anti-cancer Drugs) Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Roche
  • 11.1.1 Roche Company Details
  • 11.1.2 Roche Business Overview
  • 11.1.3 Roche Oncology (Anti-cancer Drugs) Introduction
  • 11.1.4 Roche Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.1.5 Roche Recent Development
• 11.2 Novartis
  • 11.2.1 Novartis Company Details
  • 11.2.2 Novartis Business Overview
  • 11.2.3 Novartis Oncology (Anti-cancer Drugs) Introduction
  • 11.2.4 Novartis Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.2.5 Novartis Recent Development
• 11.3 Celgene
  • 11.3.1 Celgene Company Details
  • 11.3.2 Celgene Business Overview
  • 11.3.3 Celgene Oncology (Anti-cancer Drugs) Introduction
  • 11.3.4 Celgene Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.3.5 Celgene Recent Development
• 11.4 Amgen
  • 11.4.1 Amgen Company Details
  • 11.4.2 Amgen Business Overview
  • 11.4.3 Amgen Oncology (Anti-cancer Drugs) Introduction
  • 11.4.4 Amgen Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.4.5 Amgen Recent Development
• 11.5 Johnson & Johnson
  • 11.5.1 Johnson & Johnson Company Details
  • 11.5.2 Johnson & Johnson Business Overview
  • 11.5.3 Johnson & Johnson Oncology (Anti-cancer Drugs) Introduction
  • 11.5.4 Johnson & Johnson Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.5.5 Johnson & Johnson Recent Development
• 11.6 GlaxoSmithKline
  • 11.6.1 GlaxoSmithKline Company Details
  • 11.6.2 GlaxoSmithKline Business Overview
  • 11.6.3 GlaxoSmithKline Oncology (Anti-cancer Drugs) Introduction
  • 11.6.4 GlaxoSmithKline Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.6.5 GlaxoSmithKline Recent Development
• 11.7 Eli lilly & Co
  • 11.7.1 Eli lilly & Co Company Details
  • 11.7.2 Eli lilly & Co Business Overview
  • 11.7.3 Eli lilly & Co Oncology (Anti-cancer Drugs) Introduction
  • 11.7.4 Eli lilly & Co Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.7.5 Eli lilly & Co Recent Development
• 11.8 Pfizer
  • 11.8.1 Pfizer Company Details
  • 11.8.2 Pfizer Business Overview
  • 11.8.3 Pfizer Oncology (Anti-cancer Drugs) Introduction
  • 11.8.4 Pfizer Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.8.5 Pfizer Recent Development
• 11.9 Merck & Co.
  • 11.9.1 Merck & Co. Company Details
  • 11.9.2 Merck & Co. Business Overview
  • 11.9.3 Merck & Co. Oncology (Anti-cancer Drugs) Introduction
  • 11.9.4 Merck & Co. Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.9.5 Merck & Co. Recent Development
• 11.10 Sanofi
  • 11.10.1 Sanofi Company Details
  • 11.10.2 Sanofi Business Overview
  • 11.10.3 Sanofi Oncology (Anti-cancer Drugs) Introduction
  • 11.10.4 Sanofi Revenue in Oncology (Anti-cancer Drugs) Business (2016-2021)
  • 11.10.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer